{"id":"https://openalex.org/W2967653315","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e20008","title":"Identifying TRKA and TRKB specific pathways in neuroblastoma through phosphoproteomic analysis.","display_name":"Identifying TRKA and TRKB specific pathways in neuroblastoma through phosphoproteomic analysis.","publication_year":2012,"publication_date":"2012-05-20","ids":{"openalex":"https://openalex.org/W2967653315","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e20008","mag":"2967653315"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.30.15_suppl.e20008","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e20008","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.e20008","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025529163","display_name":"Samuel L. Volchenboum","orcid":"https://orcid.org/0000-0001-9863-851X","observed_orcids":["https://orcid.org/0000-0001-9863-851X"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel Louis Volchenboum","raw_affiliation_strings":["University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031631642","display_name":"Kolbr\u00fan Kristj\u00e1nsd\u00f3ttir","orcid":"https://orcid.org/0000-0001-7054-2444","observed_orcids":["https://orcid.org/0000-0001-7054-2444"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kolbrun Kristjansdottir","raw_affiliation_strings":["University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005255746","display_name":"Ilana Bergelson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ilana Bergelson","raw_affiliation_strings":["University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112829092","display_name":"Saira Saeed Khan","orcid":"https://orcid.org/0000-0002-7397-3108","observed_orcids":["https://orcid.org/0000-0002-7397-3108"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saira Khan","raw_affiliation_strings":["University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004950779","display_name":"Garrett M. Brodeur","orcid":"https://orcid.org/0000-0002-6721-122X","observed_orcids":["https://orcid.org/0000-0002-6721-122X"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Garrett M. Brodeur","raw_affiliation_strings":["The Children's Hospital of Philadelphia, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Children's Hospital of Philadelphia, Philadelphia, PA","institution_ids":["https://openalex.org/I1335321130"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"15_suppl","first_page":"e20008","last_page":"e20008"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10519","display_name":"Advanced Proteomics Techniques and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":1.0},{"id":"https://openalex.org/keywords/trka","display_name":"TrkA","score":0.7059999704360962},{"id":"https://openalex.org/keywords/trkb","display_name":"TrkB","score":0.9919999837875366},{"id":"https://openalex.org/keywords/neurotrophin-receptors","display_name":"neurotrophin receptors","score":0.7009999752044678},{"id":"https://openalex.org/keywords/nerve-growth-factor","display_name":"nerve growth factor","score":0.6430000066757202},{"id":"https://openalex.org/keywords/brain-derived-neurotrophic-factor","display_name":"brain-derived neurotrophic factor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lestaurtinib","display_name":"lestaurtinib","score":0.9269999861717224},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7839999794960022},{"id":"https://openalex.org/keywords/phosphoproteomics","display_name":"phosphoproteomics","score":0.7360000014305115},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.7559999823570251},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mycn","display_name":"MYCN","score":0.8610000014305115},{"id":"https://openalex.org/keywords/sh-sy5y-cells","display_name":"SH-SY5Y cells","score":0.9380000233650208},{"id":"https://openalex.org/keywords/post-translational-modification","display_name":"post-translational modification","score":0.7699999809265137},{"id":"https://openalex.org/keywords/signaling-pathways","display_name":"signaling pathways","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C171034665","wikidata":"https://www.wikidata.org/wiki/Q14897694","display_name":"Tropomyosin receptor kinase A","level":4,"score":0.9074629545211792},{"id":"https://openalex.org/C97124661","wikidata":"https://www.wikidata.org/wiki/Q14897782","display_name":"Tropomyosin receptor kinase B","level":4,"score":0.9049486517906189},{"id":"https://openalex.org/C134139212","wikidata":"https://www.wikidata.org/wiki/Q24719927","display_name":"Trk receptor","level":4,"score":0.6172465682029724},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5433034300804138},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5249038934707642},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.49848175048828125},{"id":"https://openalex.org/C79186569","wikidata":"https://www.wikidata.org/wiki/Q14897880","display_name":"Tropomyosin receptor kinase C","level":5,"score":0.46669700741767883},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.44095396995544434},{"id":"https://openalex.org/C56703729","wikidata":"https://www.wikidata.org/wiki/Q14897872","display_name":"Low-affinity nerve growth factor receptor","level":4,"score":0.4166823625564575},{"id":"https://openalex.org/C92020748","wikidata":"https://www.wikidata.org/wiki/Q420457","display_name":"Neurotrophin","level":3,"score":0.39925065636634827},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3831807076931},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.37531888484954834},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35442280769348145},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3494340777397156},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.34714990854263306},{"id":"https://openalex.org/C160539049","wikidata":"https://www.wikidata.org/wiki/Q3064187","display_name":"Neurotrophic factors","level":3,"score":0.21364092826843262},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19610115885734558},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.12619075179100037},{"id":"https://openalex.org/C180361614","wikidata":"https://www.wikidata.org/wiki/Q7202242","display_name":"Platelet-derived growth factor receptor","level":4,"score":0.113040030002594}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2012.30.15_suppl.e20008","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e20008","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.e20008","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4403303688","https://openalex.org/W2033529533","https://openalex.org/W3205723961","https://openalex.org/W2003489735","https://openalex.org/W6922786533","https://openalex.org/W2130429400","https://openalex.org/W2049445546","https://openalex.org/W1494730343","https://openalex.org/W2600431475","https://openalex.org/W2104320396"],"abstract_inverted_index":{"e20008":[0],"Background:":[1],"Neuroblastoma":[2],"is":[3,13,28,42],"the":[4,32,39,56,71,159,249,289],"most":[5,43],"common":[6],"solid":[7],"tumor":[8,269],"found":[9,45],"in":[10,35,47,55,78,144,179,215,251,282],"children":[11],"and":[12,20,62,81,91,105,114,131,156,172,177,184,190,197,208,218,225,234,236,285],"difficult":[14],"to":[15,158,288],"treat":[16],"given":[17],"its":[18],"genetic":[19],"clinical":[21,145],"heterogeneity.":[22],"The":[23,188],"tyrosine":[24,140],"kinase":[25,141],"receptor,":[26],"TrkB,":[27],"often":[29,44],"co-expressed":[30],"with":[31,119,127,135,154,195,210],"MYCN":[33],"oncogene":[34],"high-risk":[36],"tumors,":[37],"whereas":[38],"TrkA":[40,121,180,189],"receptor":[41],"expressed":[46],"low-risk,":[48],"non-MYCN":[49],"amplified":[50],"samples.":[51],"There":[52],"are":[53,227],"differences":[54,77,238,250],"gene":[57],"expression":[58,175],"profiles":[59],"of":[60,206,277,291],"TrkB-":[61],"TrkA-over-expressing":[63],"cell":[64,115],"lines,":[65],"but":[66],"they":[67],"do":[68],"not":[69],"explain":[70],"phenotypic":[72],"variation.":[73],"We":[74,95,166],"hypothesize":[75],"that":[76],"protein":[79,163,174,216,252],"translation":[80],"post-translational":[82,262],"modifications":[83,263],"have":[84,167],"profound":[85],"downstream":[86],"effects":[87],"on":[88,109],"cellular":[89],"signaling":[90,279],"disease":[92],"phenotype.":[93,270],"Methods:":[94],"performed":[96,168],"quantitative":[97,169,231],"proteomics":[98],"using":[99],"stable":[100],"isotope":[101],"labeling,":[102],"phosphopeptide":[103],"enrichment,":[104],"tandem":[106],"mass":[107,160],"spectrometry":[108],"parental":[110,185],"SY5Y":[111,186],"neuroblastoma":[112,283],"cells":[113],"lines":[116],"stably":[117],"transfected":[118],"either":[120],"or":[122,129],"TrkB.":[123],"Receptors":[124],"were":[125,148,193],"activated":[126,194],"NGF":[128,196],"BDNF":[130,198],"activation":[132,220],"was":[133],"inhibited":[134],"CEP-701":[136],"(Lestaurtinib),":[137],"a":[138],"selective":[139],"inhibitor,":[142],"currently":[143],"trials.":[146],"Samples":[147],"separated":[149],"by":[150,203,212,230],"gel":[151],"electrophoresis,":[152],"digested":[153],"trypsin,":[155],"applied":[157],"spectrometer":[161],"for":[162,259,294],"identification.":[164],"Results:":[165],"phosphoproteomic":[170,232],"analysis":[171],"compared":[173],"levels":[176],"patterns":[178],"overexpressing,":[181,183],"TrkB":[182,191],"cells.":[187],"receptors":[192],"ligands,":[199],"respectively,":[200],"as":[201,265],"evidenced":[202],"increased":[204],"phosphorylation":[205,266],"ERK":[207],"AKT,":[209],"inhibition":[211,226],"CEP-701.":[213],"Changes":[214],"abundance":[217],"pathway":[219],"following":[221],"both":[222],"ligand":[223],"binding":[224],"being":[228],"determined":[229],"analysis,":[233],"TrkA-specific":[235],"TrkB-specific":[237],"will":[239],"be":[240],"presented.":[241],"Conclusions:":[242],"As":[243],"current":[244],"genomic":[245],"techniques":[246],"may":[247,273,286],"underestimate":[248],"expression,":[253],"proteomic":[254],"profiling":[255],"holds":[256],"great":[257],"promise":[258],"describing":[260],"how":[261],"such":[264],"can":[267],"affect":[268],"Our":[271],"work":[272],"reveal":[274],"key":[275],"elements":[276],"TRK":[278],"pathways":[280],"important":[281],"tumorigenesis,":[284],"lead":[287],"identification":[290],"novel":[292],"targets":[293],"therapy":[295],"development.":[296]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-08-22T00:00:00"}